Salivary levels of IL-1β [27], TNF-α [28,29], and IL-6 [28,30] have previously been reported to be elevated in OLP patients compared with healthy controls, suggesting that these cytokines may be used as disease-related biomarkers for monitoring of disease activity and response to various therapies. This evidence concerns the gene IL6 and oral lichen planus.